Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 11.08.2026
https://research-hub.de/companies/dermapharm-holding-se
Dermapharm Holding (DMP) reported H1 26 revenue of EUR 591m, slightly ahead of consensus, while adj. EBITDA of EUR 163.2m was broadly in line with our estimates of EUR 164.5m. The adj. EBITDA margin improved 1.8ppt yoy to 27.6%, although implied Q2 profitability moderated to 26.6%. Management confirmed FY26 guidance of EUR 1.18-1.22bn revenue and EUR 331-341m adj. EBITDA, implying a stronger H2 margin profile. We leave our estimates and EUR 49.50 PT unchanged. Following the BaFinrelated share-price weakness, upside has widened sufficiently to upgrade Dermapharm from HOLD to BUY. The full update can be downloaded under https://research-hub.de/companies/dermapharm-holding-se
Mon, 10.08.2026
Deutsche Rohstoff AG
Company Name:
Deutsche Rohstoff AG
ISIN:
DE000A0XYG76
Reason for the research:
Update
Recommendation:
Buy
from:
10.08.2026
Target price:
€115
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on Deutsche Rohstoff AG (ISIN: DE000A0X [ … ]
Mon, 10.08.2026
Rosenbauer International AG
Company Name:
Rosenbauer International AG
ISIN:
AT0000922554
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 71
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Q2 26: New record order backlog, profitability strengthened
On Friday, Rosenbauer released its H1 results. The [ … ]
Mon, 10.08.2026
Bittium Oyj
Company Name:
Bittium Oyj
ISIN:
FI0009007264
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 42
Target price on sight of:
12 months
Last rating change:
Analyst:
Julius Neittamo
Q2 review: Blow out sales and order intake; PT UPBittium printed an exceptional Q2. Sales grew 60.1% yoy to € 36.6m (eNuW: &e [ … ]
Mon, 10.08.2026
https://research-hub.de/companies/the-payments-group-holding
The Payments Group Holding (PGH) disclosed financial targets for holdings AuctionTech (36% stake; target revenue of several million EUR by 2030) and Cognicare AI (23% stake; €5m run-rate by 2029), alongside expanding AI ventures Cobo (up to 26.4% effective stake) and Socrivo via Softmax AI. Back-of-the-envelope calculations confirm that achieving these operational milestones yields equity value contributions far above PGH's current market cap (
Mon, 10.08.2026
https://research-hub.de/companies/brenntag-se
Brenntag’s second guidance upgrade in seven weeks materially raises the FY26 earnings floor, with the new midpoint implying H2 operating EBITDA of c.EUR 644m, or c.+7% yoy, versus c.-5% under the previous guidance. We believe the stronger Q3 start reflects the continued pricing benefit from unresolved Strait of Hormuz-related supply disruption, supporting spreads and near-term earnings. However, the earnings uplift is thus temporary and not yet driven by a genuine recovery in underlying chemical demand. We raise our estimates and price target to EUR 65.00 from EUR 60.00, while maintaining HOLD: at c.7.6x 2027E EV/operating EBITDA, valuation is not demanding, but further upside requires sustainable recovery in the underlying demand. The full update can be downloaded under https://research-hub.de/companies/brenntag-se
Mon, 10.08.2026
https://research-hub.de/companies/gea-group-ag
GEA delivered a strong Q2, with organic sales growth of 11.0% and EBITDA before restructuring of EUR 251m, clearly ahead of consensus. The EBITDA margin expanded 90bp yoy to 17.4%, while order intake grew 14.2%, confirming broad based demand momentum. Management consequently raised FY26 guidance already in July across all three KPIs, now targeting 6-8% organic growth, a 17.0-17.4% EBITDA margin and 36- 40% ROCE. With H1 growth already at 8.2%, we consider the upgraded targets achievable. GEA remains a low beta compounder with resilient end markets, a rising margin and ROCE profile, a growing backlog and a capital return story which does not get affected by crisis. We confirm our price target of EUR 76.00. BUY. The full update can be downloaded under https://research-hub.de/companies/gea-group-ag
Fri, 07.08.2026
GFT Technologies SE
Company Name:
GFT Technologies SE
ISIN:
DE0005800601
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 32
Target price on sight of:
12 months
Last rating change:
Analyst:
Simon Keller
Growth and margins moving higher
GFT delivered a strong Q2, with growth accelerating and profitability improving further. Sal [ … ]
Fri, 07.08.2026
OHB SE
Company Name:
OHB SE
ISIN:
DE0005936124
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 340
Target price on sight of:
12 months
Last rating change:
Analyst:
Simon Keller
Positioned for the award cycle
Q2 delivered margin expansion on more moderate growth, while the contracts underpinning the investment cas [ … ]
Fri, 07.08.2026
Westwing Group SE
Company Name:
Westwing Group SE
ISIN:
DE000A2N4H07
Reason for the research:
Update
Recommendation:
BUY
Target price:
EUR 23.5
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Q2 with strong growth, confirming the investment case
Growth accelerated further to the strongest print in years, with [ … ]
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Information regarding Product Information
Tuesday, 18.08.2026, Calendar Week 34, 230th day of the year, 135 days remaining until EoY.